Hikma Pharmaceuticals
Founded in Jordan in 1978, today the largest generic pharma group in MENA.
Hikma Pharmaceuticals was founded in 1978 in Amman and has grown into the largest pharmaceutical company in the MENA region, operating 29 manufacturing plants across 10 countries with an 800+ product portfolio spanning injectable, oral, and branded generic medicines. In Jordan, Hikma runs four plants covering general formulation, cephalosporins, penicillin, and oncology, all inspected by the US FDA. The company distributes to approximately 50 countries including major markets in North America, Europe, and across MENA.
- Type
- Manufacturer
- Location
- Amman, Jordan
- Founded
- 1978
- Website
- hikma.com
- Categories
- Medical & Healthcare Supplies
- Markets
- United States, United Kingdom, Germany, Saudi Arabia, United Arab Emirates, Egypt, Morocco, Nigeria, South Africa
Verified facts
- corporate-mail-on-domain (green), checked 2026-08-08 Mail server of the company domain
- domain-registered (green), checked 2026-08-08 Domain registry record
- sanctions-clear (green), checked 2026-08-08 OpenSanctions
- debarment-clear (green), checked 2026-08-08 OpenSanctions
- web-presence-since (green), checked 2026-08-04 Internet Archive (Wayback)
Claimed certifications
- Good Manufacturing Practice
- ISO 9001, Quality Management IAF CertSearch
- FDA Registered FDA Establishment Registration
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)